about
Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?Epigenetics of lung cancerSPARC Promotes Cell Invasion In Vivo by Decreasing Type IV Collagen Levels in the Basement MembraneCommon deleted genes in the 5q- syndrome: thrombocytopenia and reduced erythroid colony formation in SPARC null mice.SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response.Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma.Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.Demethylating Agents in the Treatment of CancerMethylation of the SPARC gene promoter and its clinical implication in pancreatic cancer.Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer.Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors.KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression.SPARC gene expression is repressed in human urothelial cells (UROtsa) exposed to or malignantly transformed by cadmium or arsenite.Anti-cancer role of SPARC, an inhibitor of adipogenesisRevisiting the matricellular concept.Shortening of 3'UTRs correlates with poor prognosis in breast and lung cancer.Aberrant methylation of SPARC in human hepatocellular carcinoma and its clinical implication.Aberrant methylation of secreted protein, acidic and rich in cysteine in human laryngeal and hypopharyngeal carcinoma.DNA methylation: its role in lung carcinogenesis and therapeutic implications.Epigenetics of lung cancer.SPARC ameliorates ovarian cancer-associated inflammation.Aberrant promoter methylation of SPARC in ovarian cancerFirst line treatment of advanced non-small-cell lung cancer - specific focus on albumin bound paclitaxel.Complete response to azacitidine priming and nab-paclitaxel in non-Hodgkin lymphoma resistant to biochemotherapy.SPARC: a matricellular regulator of tumorigenesis.Genetic and epigenetic changes in lung carcinoma and their clinical implications.Role of SPARC in bone remodeling and cancer-related bone metastasis.Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis.The nonsteroidal anti-inflammatory drug NS398 reactivates SPARC expression via promoter demethylation to attenuate invasiveness of lung cancer cells.Decorin gene upregulation mediated by an adeno-associated virus vector increases intratumoral uptake of nab-paclitaxel in neuroblastoma via inhibition of stabilin-1.A phase I trial of azacitidine and nanoparticle albumin bound paclitaxel in patients with advanced or metastatic solid tumors.Inflammation-dependent expression of SPARC during development of chronic pancreatitis in WBN/Kob rats and a microarray gene expression analysis.Methylation of the APAF-1 and DAPK-1 promoter region correlates with progression of renal cell carcinoma in North Indian population.Aberrant DNA methylation of tumor-related genes in oral rinse: a noninvasive method for detection of oral squamous cell carcinoma.[Correlation of KLF4 and SPARC expression with the clinical characteristics of non-small cell lung cancer].
P2860
Q26828777-42C41AEF-1917-4513-9A7B-27CC27098BB9Q26996766-1D5300A4-2D4B-4147-BE16-B869015E83BCQ27309073-A7B27BB7-F025-425D-9618-04B78F2D70BEQ30157922-DE21AFD3-F0A2-42B0-8085-C6F2A7AB2FA0Q33331870-1425AB8A-D113-4CDD-B941-8B57F1F8A0FBQ33592374-847023D8-1925-4BF7-B940-A021BA9CC9F9Q33603723-7F509245-3CFB-4F95-8C57-ADC8C7FD4605Q33678040-42769657-0EDF-42E1-9597-165BCE6826C7Q33820209-AF8BADB2-2BE9-4586-B14C-64FF060528A5Q33955148-33DDEE61-A10B-459A-A1EF-FA7B27DC839CQ33955200-102AE970-85CF-46B8-9EA7-ED83595434E0Q33987695-B2ADA4F6-D900-48DA-BBEC-20DBD1CCA75EQ34208905-71CB3980-5785-4CFB-9E34-5F6E21133B58Q35116107-8BEC5DCD-C71A-4AEC-AB4B-0603BCAF7567Q35233858-0AFC8032-A2DE-4A5F-9825-FACDA4B26401Q35745093-9F8F0738-E5B2-4AD2-8B4D-E0EC799A8E6BQ35929159-D6B2F725-1C9C-455B-A949-F36EDF2E474DQ36120937-25A4A584-A5E0-4A2F-AC21-15D0E985E0AAQ36235566-C3B42533-E73E-4114-891B-6C80D9A037A6Q36505767-1CD3638A-684F-41DF-B1CE-0A966834B066Q36897774-9D17248B-B67E-4E83-91D3-8CBD07ADE2D7Q37073261-3013D4FF-F854-4EA1-A5B1-D417E08920A3Q37419857-F836408F-1178-47DE-A411-80BA51B355B7Q37594238-B4FD396C-3558-4475-8FBE-2D0370222B8EQ37610020-BFE93BCD-0C98-4193-AC1E-E2CCBD91FF14Q37855515-D3F2A826-EB74-47D6-8902-AF6324D322AEQ38137862-C2C4498F-35C2-4BF5-96A6-285A6293F443Q38199932-753767A9-DC28-4E96-921C-A806D78B7DA4Q39998314-F04D8A4C-28B1-4B8A-864A-07677C7B84A9Q40153387-EB59B8E2-2169-4010-91BE-E19EE82E9925Q41592735-74338EDA-D912-42D5-A8BC-3E2D92DEDF5CQ47819651-0A9A6C01-331E-4887-AC3D-00361B920DF2Q51413061-BCD439B9-961D-495B-A750-817DFADFB172Q54328688-4704928B-085E-4418-97C5-BB911D196271Q55427213-DBA01C05-7D85-4E67-93D5-1BA900295FF8
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Aberrant methylation of SPARC in human lung cancers.
@ast
Aberrant methylation of SPARC in human lung cancers.
@en
type
label
Aberrant methylation of SPARC in human lung cancers.
@ast
Aberrant methylation of SPARC in human lung cancers.
@en
prefLabel
Aberrant methylation of SPARC in human lung cancers.
@ast
Aberrant methylation of SPARC in human lung cancers.
@en
P2093
P2860
P356
P1476
Aberrant methylation of SPARC in human lung cancers.
@en
P2093
A F Gazdar
H Shigematsu
K Hiroshima
N Shivapurkar
T Fujisawa
T Takahashi
U G Sathyanarayana
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602376
P407
P577
2005-03-01T00:00:00Z